Skip to search formSkip to main contentSkip to account menu

Aracytin

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Cytarabine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Reduced expression of hepcidin in patients with myelodysplastic syndrome and myelofibrosis: the causes might be more heterogeneous than in thalassaemia
Baer, M.R., Stewart, C.C., Dodge, R.K., Leget, G., Sule, N., Mrozek, K., Schiffer, C.A., Powell, B.L., Kolitz, J.E., Moore, J.O… 
2008
2008
Fotemustine, Etoposide, Aracytin and Melphalan (FEAM), a Different Conditioning Regimen for Lymphoma Treatment with Autologous Hemopoietic Stem-Cell Transplantation
Introduction . BEAM (carmustine, etoposide, aracytin, melphalan) is a conditioning regimen used in autologous hemopoietic stem… 
2006
2006
Efficacy of single dose pegfilgrastim in enhancing the mobilization of CD34+ peripheral blood stem cells in aggressive lymphoma patients treated with cisplatin-aracytin-containing regimens
Systematic data on the ability of pegfilgrastim to mobilize stem cells after chemotherapy are scarce. We evaluated the efficacy… 
2006
2006
MIDAM Regimen (Mylotarg + Intermediaite Dose Aracytin + Mitoxantrone) Is an Effective Combination of Chemo-Immunotherapy for Relapsed/Refractory CD33+ AML Patients.
Introduction: Refractory and relapsed AML patients have very poor outcome. Recently we have described a new combination of chemo… 
2005
2005
Administration of mylotarg 4 days after beginning of a chemotherapy including intermediate-dose aracytin and mitoxantrone (MIDAM regimen) produces a high rate of complete hematologic remission in…
2004
2004
A single-center, retrospective study of management and outcome of 45 elderly AML patients, diagnosed in 2001.
Acute myeloid leukemia (AML) predominantly affects older adults, a population with a poor prognosis, due to age, comorbidities… 
1998
1998
Phase I–II Study of Carboplatin with VP16 and Aracytin for Poor-Risk-Acute Leukemia
We conducted a phase I–II trial of escalating dose of carboplatin (CB) 0.750, 0.875, 1000 g/m2 (level 1, 2, 3 respectively) given… 
1996
1996
First line immunochemotherapy with cisplatin-based protocol by intraperitoneal and intravenous routes in ovarian cancer: technique and results of 82 cases.
1994
1994
Long-term continuous complete remission of acute myeloid leukemia in a Jehovah's witness treated without blood support.
We report the case of a young female patient, a Jehovah's witness, affected by peroxidase-positive acute leukemia. The patient… 
1991
1991
Oral idarubicin plus cytosine arabinoside in the treatment of acute non lymphoblastic leukemia in elderly patients.
Eighteen acute nonlymphoblastic leukemia patients greater than 60 yr., 12 at diagnosis and 6 in first relapse, were treated with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)